Probiotic drug interactions in ulcerative colitis: a microbiota and metabolite perspective
An up-to-date overview of probiotic-drug interactions in UC is provided, with particular emphasis on microbiota- and metabolite-mediated mechanisms that may influence therapeutic efficacy and contribute to interindividual variability in treatment response.